| Literature DB >> 27301427 |
Katarzyna Danis-Wlodarczyk1,2, Dieter Vandenheuvel2, Ho Bin Jang2, Yves Briers2,3, Tomasz Olszak1, Michal Arabski4, Slawomir Wasik5, Marcin Drabik6, Gerard Higgins7,8, Jean Tyrrell8, Brian J Harvey8, Jean-Paul Noben9, Rob Lavigne2, Zuzanna Drulis-Kawa1.
Abstract
Bacteriophage therapy is currently resurging as a potential complement/alternative to antibiotic treatment. However, preclinical evaluation lacks streamlined approaches. We here focus on preclinical approaches which have been implemented to assess bacteriophage efficacy against Pseudomonas biofilms and infections. Laser interferometry and profilometry were applied to measure biofilm matrix permeability and surface geometry changes, respectively. These biophysical approaches were combined with an advanced Airway Surface Liquid infection model, which mimics in vitro the normal and CF lung environments, and an in vivo Galleria larvae model. These assays have been implemented to analyze KTN4 (279,593 bp dsDNA genome), a type-IV pili dependent, giant phage resembling phiKZ. Upon contact, KTN4 immediately disrupts the P. aeruginosa PAO1 biofilm and reduces pyocyanin and siderophore production. The gentamicin exclusion assay on NuLi-1 and CuFi-1 cell lines revealed the decrease of extracellular bacterial load between 4 and 7 logs and successfully prevents wild-type Pseudomonas internalization into CF epithelial cells. These properties and the significant rescue of Galleria larvae indicate that giant KTN4 phage is a suitable candidate for in vivo phage therapy evaluation for lung infection applications.Entities:
Mesh:
Substances:
Year: 2016 PMID: 27301427 PMCID: PMC4908380 DOI: 10.1038/srep28115
Source DB: PubMed Journal: Sci Rep ISSN: 2045-2322 Impact factor: 4.379
Figure 1Protein-sharing network for KTN4.
(A) A network representation was produced using the edge-weighted spring embedded layout of Cytoscape version 3.1.1. Nodes indicate phage genomes and edges between two nodes indicate their statistically weighted pairwise similarities with phage-phage similarity scores of ≥1. There are 495 nodes and 6,948 edges in this network. (B) An enlarged view of the circle in Panel B. Values are the similarity scores estimated with the hypergeometric equation shown in Materials and methods. Edge thickness is proportional to protein sequence identity, which is represented in the legend box.
Phage receptor identification on P. aeruginosa PAO1 mutants.
| Bacterial strain | Phenotype | Origin | KTN4 | φKZ |
|---|---|---|---|---|
| PAO1 (ATCC 15692) | Wild type | American Type Culture Collection | + | + |
| PAO1 Pirnay | Wild type with inactive type IV pili | Military Hospital Nederoverheembeek, Brussels, Belgium, Dr. Jean-Paul Pirnay | − | − |
| PAO1 Krylov | Wild type | Military Hospital Nederoverheembeek, Brussels, Belgium, Dr. Jean-Paul Pirnay | + | + |
| PAO1 Δrmd (A−, B+) | Deficiency in D-rhamnose biosynthesis; lack of A-band LPS | Laboratory of Foodborne Zoonoses, Guelph, Canada, Andrew M. Kropinski | + | + |
| PAO1 ΔrmLC (A−, B−, core-) | Deficiency in L-rhamnose biosynthesis; truncate core region, lack of A-band and B-band LPS | Laboratory of Foodborne Zoonoses, Guelph, Canada, Andrew M. Kropinski | + | + |
| PAO1 ΔwaaL (A−, B−) | Lack of WaaL ligating O-polymer to core-lipid A; LPS is devoid of A-band and B-band, semirough (SR-LPS, or core-plus-one O-antigen) | Laboratory of Foodborne Zoonoses, Guelph, Canada, Andrew M. Kropinski | + | + |
| PAO1 ΔwbpL (A−, B−) | Lack of glucosyltransferase WbpL essential for initiation of both A-band and B-band synthesis | Laboratory of Foodborne Zoonoses, Guelph, Canada, Andrew M. Kropinski | + | + |
| PAO1 ΔfliC ΔalgC ΔpilA | Lack of flagella; lack of AlgC required for A-band, core oligosaccharide, and alginate biosynthesis; lack of type IV pili | Technical University Hamburg, Germany, Max Schöbert | − | − |
| PAO1 ΔfliC wt algC ΔpilA | Lack of flagella; lack of type IV pili | Technical University Hamburg, Germany, Max Schöbert | − | − |
| PAO1 ΔfliC wt algC wt pilA | Lack of flagella | Technical University Hamburg, Germany, Max Schöbert | + | + |
| PAO1 wt fliC wt algC wt pilA | Wild type | Technical University Hamburg, Germany, Max Schöbert | + | + |
Figure 2The antibacterial effect of colistin against 24 h PAO1 biofilm formed on Nephrophane membrane (A); the anti-biofilm effect of KTN4 phage/colistin treatment on 24, 48 and 72 h PAO1 biofilm formed on Nephrophane membrane: the biomass evaluation by CV staining (B); the level of pyocyanin in growth medium (C); the fluorescence of pyoverdin in growth medium (D). Untreated biofilm was used as control. The results are presented as the means ± SD. Statistical analysis was made by the ANOVA test (denoted p-values < 0.05).
Figure 3Laser interferometry analysis of TSB medium diffusion through PAO1 biofilm treated with phages.
Untreated biofilm was used as control. The results are presented as the means ± SD from three independent experiments.
Figure 4The 3D surface optical profile analysis of Nephrophane membrane, PAO1 biofilm and PAO1 biofilm after KTN4 phage bacteriophage degradation measured by ZET 20 instrument (A). The Nephrophane roughness (R) parameters measured by ZET 20 (B). The results are presented as the means ± SD. Statistical analysis was made using an ANOVA test (denoted p-values < 0.05).
Figure 5Phage KTN4 treatment of P. aeruginosa infected NuLi-1 and CuFi-1 epithelial cells.
(A) Colony count of bacteria collected from apical wash; (B) colony count of bacteria internalized in epithelial cells. The results are presented as the means ± SD. Statistical analysis was made by the ANOVA test (denoted p-values < 0.05).
Figure 6Antibacterial activity of KTN4 phage (MOI 100) in the treatment of infected Galleria larvae by PA strains.
Positive control consisted of infected but untreated larvae and KTN4 control was larvae group receiving phage lysate only. Statistical analysis was calculated for pair wise comparisons between infected larvae and phage treated infected larvae using Mantel-Cox test (denoted p-values < 0.05).